Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics

Paola Bianchi(University of Pavia), Andréa Zanella(University of Padua), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Anna Paola Marcello(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Laura Porretti(Ospedale Maggiore), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Elisa Fermo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Cristina Vercellati(Ospedale Maggiore)
Haematologica
November 4, 2011
10.3324/haematol.2011.052845
Cited by 183

Related Papers

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|373
Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle
|Journal of Clinical Investigation|2004|365
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309